For: | Bianca C, Sidhartha E, Tiribelli C, El-Khobar KE, Sukowati CHC. Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA . World J Hepatol 2022; 14(5): 866-884 [PMID: 35721287 DOI: 10.4254/wjh.v14.i5.866] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i5/866.htm |
Number | Citing Articles |
1 |
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B. Annals of Hepatology 2025; 30(1): 101533 doi: 10.1016/j.aohep.2024.101533
|
2 |
Corina Rotãrescu, Mariana Gelinas Martín del Campo, Ion Mãrunțelu. CHRONIC HEPATITIS B VIRUS INFECTION: WHERE WE ARE NOW. Romanian Archives of Microbiology and Immunology 2022; 81(3): 203 doi: 10.54044/RAMI.2022.03.05
|
3 |
Yassir Hamadalnil, Hisham N. Altayb. In silico molecular study of hepatitis B virus X protein as a therapeutic target. Journal of Biomolecular Structure and Dynamics 2024; 42(8): 4002 doi: 10.1080/07391102.2023.2217920
|
4 |
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Sang Hoon Ahn, Won Kim, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Sun Young Yim, Jin Kyung Park, Soon Ho Um. Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy. Cancers 2024; 16(5): 887 doi: 10.3390/cancers16050887
|